Embedding Owner-Manager Values in the Small and Medium Sized Enterprise Context: A Lockean Conceptualisation
Journal of Business Ethics
An early-stage study has found that a drug commonly prescribed for diabetes may prove to help treat people with alcohol use disorder. The study, published in Alcohol: Clinical and Experimental Research, found that the diabetes drug metformin reduced alcohol intake in mice.
Using antibiotics alone to treat children with uncomplicated appendicitis is a cost-saving alternative to surgery.
A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical treatments such as wound healing, cancer therapy and even organ regeneration, according to a research team at Penn State.
A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell death can actually make tumors grow faster by turning off the immune system’s ability to fight the cancer.
A groundbreaking study published in Science has achieved a significant advancement in thermal photonics, enabling efficient subambient daytime radiative cooling for vertical surfaces.
Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the 47th annual San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center from December 10 to 13.
Scientists have unveiled a strategy to amplify the catalytic power of two-dimensional NiPS3 monolayers for hydrogen evolution reactions (HER). By introducing and strategically manipulating atomic vacancies, this innovative approach enhances the material’s ability to split water molecules and absorb protons.
Digital Science is pleased to announce that global professional services firm Huron will integrate Dimensions Research Security into its suite of services to support clients in the research and higher education sectors.
American Thyroid Association® announces Jacqueline Jonklaas, MD, PhD, as 2024-2025 President and five new officers and members of the Board of Directors.
A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.
In a significant advancement for industrial technology, scientists have introduced a revolutionary digital twin (DT) platform designed to transform the process industry. This cutting-edge platform creates a highly accurate virtual replica of physical systems, allowing companies to optimize operations, enhance productivity, and fuel innovation like never before.
Scientists are exploring non-lithium-ion batteries as a sustainable alternative to traditional lithium-ion batteries, focusing on sodium, potassium, magnesium, and calcium-ion technologies. This research is crucial for developing clean energy systems that are both environmentally friendly and rely on abundantly available elements, ensuring a more secure and eco-friendly future for energy storage.
UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease.
Walt Akers, Jefferson Lab’s chief systems engineer for experimental nuclear physics, created a 3D-printed model of a section of the Electron-Ion Collider (EIC) on a short timeline ahead of the lab’s 2024 Open House. He calls it the “Lego model.”
Two new papers show progress in researchers' work to illuminate the struggles of those living with PPA and pioneer accessible treatment models.